US FDA approves GSK's lung cancer drug
GSK•FDA approves GSK lung cancer drug for certain adults
GSK said on Wednesday the U.S. FDA has approved its drug for adults with a form of lung cancer who have previously received a targeted therapy.
Related News
Eaton declares quarterly dividend of $1.1 per share
ETN•
Nasdaq trade halt continues <PLTS.O> reason not available at 01:58 PM
PLTS•
More ships change course in Red Sea after Houthi threats, data shows
XLE•
Uwharrie Capital Q2 FY26 net income climbs 39.29% to $3.9 million
UWHR•
Chinese AI's role in stopping rogue OpenAI agent shows cost of US guardrails
QQQ•